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Introduction
the number of syphilis cases in north-Western europe 
has risen steadily since 1996, while a surge in new cases 
has been reported in the former Soviet union and other 
eastern european countries [1-10]. in Western soci-
ety, the populations most at risk for sexually transmit-
ted infections (Sti) are young persons, men who have 
sex with men (MSM), immigrant groups and inner city 
residents, whereas intravenous drug use is the leading 
cause and is mainly related to sex for drugs in eastern 
europe [11-14].
outbreaks of primary-secondary syphilis occurred in major 
italian cities in the late 1990s; in some settings, prevalently 
among MSM, the number of cases increased by 400-700% 
within just a few years [15-18].
of paramount importance in the control of the disease is 
early diagnosis, yet diagnosis poses many challenges, de-
spite the wide range of laboratory tests available [19]. easy 
access to laboratory testing is thought to be a cornerstone 
in the control of syphilis. an on-site rapid test delivered at 
the first visit as part of Sti screening in high-risk individu-
als or as a confirmatory test of clinical suspicion would 
be extremely useful in hard to reach populations.
over twenty rapid tests for the serological diagnosis of 
syphilis are commercially available [19]. the fundamental 
features of a rapid test are: availability of results within 30 
minutes, easy to perform (no expert staff needed), clear 
interpretation of results and low cost. Sti clinics, medical 
practitioners, emergency departments, youth clubs and 
community-based centers for intravenous drug users or 
drop-in centers are ideally suited places where these tests 
could be administered to identify individuals requiring 
treatment. Few studies on test validity and utility in such 
facilities have been carried out. Most have been conducted 
in rural or underdeveloped areas [20-24]. in industrialized 
countries, the use of rapid tests should be strongly promoted 
to contain the mounting numbers of contagious cases.
Several studies on the cost-effectiveness of alternative 
strategies for syphilis prevention and control have com-
pared selective screening and partner notification [25, 26]; 
others have focused on syphilis screening of specific 
populations such as pregnant women in or military recruit 
applicants [27, 28], finally other studies have evaluated 
cost-effectiveness of rapid plasma reagin test with post-
poned result end treatement and a rapid test with imme-
diate results and treatement among pregnant women for 
maternal syphilis [29-31].
the aim of this study was to evaluate the performance 
and the cost-effectiveness of an immunochromatography 
essay for syphilis rapid diagnosis in high-risk patients 
attending an urban Sti clinic.
Materials and methods
the HiV/Sti clinic in turin (an industrial city in north-
Western italy with 1 million inhabitants) is based on the 
Introduction. Rapid syphilis screening could facilitate case-
identification in populations at high risk for sexually transmit-
ted infections (STI). The aim of this study was to compare the 
performance and the cost-effectiveness of a rapid immunochro-
matography syphilis test with a traditional ELISA screening test 
in patients with suspected infectious syphilis or patients at high 
risk for STI/syphilis.
Methods. Consecutive patients attending a STI clinic cosensually 
underwent serological testing with two different tests. Sensitivity, 
specificity, Positive Predictive Values, Negative Predictive Values 
and effectiveness of the two tests were evaluated with respect to 
definitive diagnosis.
Results. In our population, the immunochromatography essay 
(Abbott Determine Syphilis TP) had a sensitivity of 95.0% (95% 
CI 88.7-97.8) and a specificity of 97.7% (95% CI 94.7-99.0). The 
ELISA test had a sensitivity of 95.0% (95% CI 88.8-97.9) and a 
specificity of 97.2% (95% CI 94.1-98.7). The Positive Predictive 
Value for ELISA was 94.1% (95% CI 87.6-97.3) and 95.0% (95% 
CI 88.7-97.8) for the rapid test. The Negative Predictive Value was 
97.7% (95% CI 94.7-99) for both ELISA and the rapid tests.
The cost-effectiveness analysis showed that the rapid test was less 
expensive than ELISA (€ 26.46 vs € 40.57) and yielded a similar 
number of right diagnoses.
Conclusions. The Abbott Determine Syphilis TP test is an accurate, 
easy and inexpensive test that could facilitate the rapid detection 
of syphilis in high-risk urban patients.
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british walk-in-clinic model and offers confidential, vol-
untary self-referral services for the early diagnosis and 
free treatment of Stis. the clinic operates at amedeo di 
Savoia Hospital, an infectious disease tertiary care insti-
tution. between 01 June 2003 and 30 September 2006, 
consecutive patients with dermatological lesions sugges-
tive of infectious syphilis or with ulcerative genital dis-
ease or patients at high risk of acquiring syphilis were of-
fered a rapid test along with traditional treponema testing. 
after being interviewed, patients gave consent to clini-
cal examination; microbiological samples were collected 
for the most common sexually transmissible pathogens. 
From each patient 7 ml of blood were drawn by trained 
personnel using the Vacutainer blood collection system 
(becton-Dickinson, rutherford, nJ, uSa). eDta-con-
taining tubes were used for the rapid tests. Specimens 
were stored at 4°C until testing with eliSa within 24 
hours at the hospital’s microbiology laboratory.
Serological screening for syphilis was carried out using 
the eliSa test (beia Mab Syphilis Screen, bouty-ita-
lia). Positive specimens were then retested with rapid 
Plasma reagin (rPr Slide-test, bioMérieux, France), 
treponema pallidum-Particle agglutination (Sero-
Dia-tP-Pa, Fujirebio, Japan), eliSa igM (beia Mab 
SYPHiliS igM Capture, bouty-italy) according to the 
manufacturer’s instructions. after reviewing World 
Health organization (WHo) results and italian market 
availability, we selected Determine Syphilis tP, an 
immunochromatographic rapid test, (abbott laborato-
ries, Chicago, il, uSa) to detect antibodies for 57 KD 
antigen of Treponema pallidum in collected specimens. 
in brief, whole blood was collected in eDta-contain-
ing vacutainer tubes; 50 ml of blood were transferred 
from the tube to the immunochromatographic strip 
by means of a micropipetter. as the sample migrates 
through the conjugate pad, it reconstitutes and mixes 
with the Treponema pallidum antigen-selenium colloid 
conjugate. the mixture continues to migrate through 
the solid phase to the immobilized Treponema pallidum 
antigens at the patient window site. a red line appears 
when anti-treponema antibodies bind to the selenium-
antigen colloid in the patient window. if the sample 
contains no antibodies, the red line does not appear be-
cause the Treponema pallidum antigen-selenium colloid 
flows past the patient window. to ensure test validity, 
an internal procedural control bar was incorporated. at 
least 15 minutes are needed before the result can be 
read. two independent readers were chosen to interpret 
the results.
Definitive syphilis diagnosis was confirmed by combin-
ing clinical stage of disease (presence of dermatologi-
cal lesions suggestive of infectious syphilis – such as 
aphthosis orogenital, candidiasis, condylomas, urethri-
tis, vaginitis – or ulcerative genital disease – such as 
herpetic infections) and positive screening test result 
(eliSa) and positive confirmatory tests result (rPr, 
tP-Pa or eliSa igM). test sensitivity, specificity, 
Positive Predictive Values, negative Predictive Values 
and effectiveness (expressed as the number of right 
diagnoses) were measured against definitive diagnosis. 
the fraction of indeterminate tests was calculated as a 
marker for test failure frequency.
the economic evaluation was carried out from the hospi-
tal’s point of view. to determine the cost of the tests, we 
referred to the data provided by the amedeo di Savoia 
Hospital. the direct internal costs to the hospital for car-
rying out the tests were calculated taking the value of: 
test price, supplies (test tubes, gloves, micropipetters, 
biotransport), labor costs laboratory technicians, nurses, 
support personnel, medical staff and personal assistants 
to perform the test and write up the medical report.
the costs of the eliSa test (specimen transport from 
ambulatory to laboratory, exhibit transport from labora-
tory to ambulatory), and second medical examination 
were also included. there were no additional laboratory 
equipment costs because they are included in the kit 
price. Hospital administration and overhead costs were 
also included in the calculation. the total costs and the 
average cost per test unit are expressed in euros. all 
costs are expressed in euros and were calculated in rela-
tion to rates 2006.
Results
During the study period, 316 consecutive patients (244 
men, median age 36 years; 72 women, median age 28.5 
years) either symptomatic for dermatological or genital 
lesions or asymptomatic patients but belonging to an at-
risk group were examined at the Sti clinic; 78% were 
italian nationals, 11% were from eastern europe, 6.5% 
from north africa and 4.5% from other countries.
table i summarizes the results of the two tests.
in this sample, the eliSa test had a sensitivity of 95.0% 
(95% Ci 88.8-97.9) and a specificity of 97.2% (95% 
Ci 94.1-98.7); the rapid test had a sensitivity of 95.0% 
(95% Ci 88.7-97.8) and a specificity of 97.7% (95% Ci 
94.7-99.0).
Tab. I. results of the rapid and elisa test.
Rapid test Definitive Syphilis Diagnosis* ELISA Definitive Syphilis Diagnosis*
+ - Total + - Total
+ 94 5 99 + 95 6 101
- 5 212 217 - 5 210 215
total 99 217 316 total 97 216 316
* definitive syphilis diagnosis was confirmed by combining clinical stage of disease (presence of dermatological lesions suggestive of infectious 
syphilis – such as aphthosis orogenital, candidiasis, condylomas, urethritis, vaginitis –, or ulcerative genital disease – such as herpetic infections) and 
positive screening test result (elisa) and positive confirmatory tests result (rpr, tp-pa or elisa igm).
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the Positive Predictive Value of eliSa was 94.1% 
(95% Ci 87.6-97.3) and that of the rapid test was 95.0% 
(95% Ci 88.7-97.8). the negative Predictive Value was 
97.7% (95% Ci 94.7-99) for both tests.
a breakdown of the unit costs per single test (in euros) 
is illustrated in table ii. the cost item that weighed 
most on the eliSa test was “second medical examina-
tion”. the “second medical examination” was needed 
for report delivery and therapeutic prescription, whereas 
performing rapid syphilis test the “second medical ex-
amination” was not necessary being contextual.
evaluation cost-effectiveness, table iii, determines less 
expensive rapid test for right diagnosis.
the difference in the costs and results of the two tests 
is readily apparent: with the rapid test – € 4,277.38 are 
saved per the additional right diagnosis.
this result remained the same even when a one-way 
sensitivity analysis was applied and the cost item that 
weighs the greatest, i.e. the “second medical examina-
tion”, was eliminated, since even after this cost is elimi-
nated, the cost of the rapid test is still less than that of 
the eliSa.
Discussion
the return of syphilis in many parts of the world re-
quires accurate and rapid diagnosis for effective control. 
Paradoxically, the diagnosis of syphilis in the developed 
countries is not an easy task. three different approaches 
are generally used: recognizing signs and symptoms in 
exposed individuals, direct demonstration of Treponema 
spp. by dark field microscopy and serological testing. 
the last is of paramount importance in the diagnostic 
process and for public health issues as well. in Sti clin-
ics, antenatal services, marginalized people centers and 
other such settings where many clients are not likely to 
return, rapid syphilis diagnosis is warranted. this means 
that treatment needs to be delivered at the same time as 
the provisional diagnosis.
our study shows that the rapid test has a high sensitiv-
ity and specificity, confirming the results of previous 
studies on abbott Determine Syphilis tP (tab. iV). our 
results also show that its sensitivity and specificity are 
comparable to those of the eliSa screening test and to 
the manufacturer’s data (sensitivity 92.3%, specificity 
100%).
as expected, the Positive Predictive Value was high, 
since the test was administered to a patient group with a 
high prevalence of syphilis (31.6%); likewise, there was 
a high probability of not having a definitive diagnosis 
of syphilis if the test result was negative. Moreover, the 
rapid test is less expensive than the eliSa test.
based on these considerations, the rapid test could re-
place the traditional syphilis test for screening in high-
risk population-based ambulatories.
in brief:
– routine administration of the test to urban high-risk 
Tab. II. estimated average cost (€) and incremental cost of the rapid and the elisa test.
Resources Rapid Test
(a)
ELISA
(b)
Incremental cost
(c) = (b) - (a)
staffing
– medical 14.62 13.28 - 1.34
– laboratory technician/nurse 2.10 3.90 + 1.80
– support personnel 0.88 + 0.88
– personal assistant 0.50 0.50 0
supplies 0.13 0.24 + 0.11
test price 4.00 1.38 - 2.62
second medical examination 12.45 12.45 0
other* 4.27 6.53 + 2.26
total 25.62 39.16 + 13.54
*includes administration and overhead costs
Tab. III. cost-effectiveness of the rapid and the elisa test in 316 patients.
Test Total Costs (€) No. of right diagnoses Costs/ No. of right diagnoses
rapid test 8,095.92 306 26.46
elisa 12,373.30 305 40.57
Tab. IV. comparison of sensitivity and specificity of the rapid test in different studies.
Study population WHO [20] Lien [21] Sato [22] Diaz [23] Siedner [24]
sensitivity 95.0% 97.2% 100% 93.7% 96.9-98.5% 88%
specificity 97.7% 94.1% 98.6% 95.2% 95.7-97.3%
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populations is recommended since it yields a result 
within 15 minutes, does not require sophisticated lab-
oratory equipment or specifically trained personnel;
– high-risk populations typically seek treatment for 
acute episodes during clinic visits and are not likely 
to return a second time for test results;
– diagnosis and treatment at the same visit can aid in 
reducing the spread of the disease and the related 
costs of treatment.
nevertheless, these statements should be interpreted 
within the correct perspective. the first limitation is 
linked to the rapid test’s characteristics. like all rapid 
tests, it is unable to discriminate between previous 
syphilis infection and re-infection since anti-treponema 
antibodies continue to remain present in the blood, mak-
ing the test useless for monitoring treatment or progress 
of the infection.
the second is that its use as a screening test for popula-
tions at low risk for syphilis is not currently advised, or 
at least not until the data from large-scale WHo studies 
have been evaluated. Similarly, the results can change 
completely for the general population, which has a sig-
nificantly lower prevalence of syphilis. the test’s sensi-
tivity and specificity in a hypothetical italian population 
of 100,000 habitual blood donors (treponema pallidum 
Hemoagglutination [tPHa] test prevalence of 0.12%) 
would yield disappointing results, thus discouraging 
its use for general population screening. as prevalence 
diminishes, so does the test’s positive predictive value, 
while the negative predictive value increases.
the results of our study suggest that the rapid test could 
meet the need for an inexpensive, noninvasive, rapid 
screening test for syphilis, but larger sample sizes are 
needed to corroborate our conclusions.
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